title: Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization.
authors.forename: Emmanuel A
authors.initials: EA
authors.lastname: Tsochatzis
authors.forename: Tim
authors.initials: T
authors.lastname: Meyer
authors.forename: James
authors.initials: J
authors.lastname: O'Beirne
authors.forename: Andrew K
authors.initials: AK
authors.lastname: Burroughs
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D011725:Pyridines